Related Experiment Video
Updated: Jun 14, 2026
11:13
Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Apigenin: a promising molecule for cancer prevention
1Department of Urology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA.
Pharmaceutical Research
|March 23, 2010
Summary
Apigenin, a plant flavone found in fruits and vegetables, shows anti-inflammatory, antioxidant, and anticancer properties. Further research is needed, but it holds potential for cancer chemoprevention and may protect against cardiovascular and neurological disorders.
Area of Science:
- Biochemistry
- Pharmacology
- Nutritional Science
Background:
- Apigenin is a naturally occurring plant flavone found in common fruits and vegetables.
- It is recognized as a bioactive flavonoid with demonstrated anti-inflammatory, antioxidant, and anticancer properties.
- Epidemiologic studies link flavone-rich diets to reduced risks of breast, digestive, skin, prostate, and hematological cancers.
Purpose of the Study:
- To review the existing evidence on apigenin's biological activities.
- To explore its potential role in disease prevention, including cancer chemoprevention.
- To identify areas for future research, particularly human clinical trials.
Main Methods:
- Literature review of epidemiological studies and preclinical research on apigenin.
- Analysis of apigenin's proposed mechanisms of action.
- Assessment of its potential therapeutic applications.
Main Results:
- Apigenin exhibits significant anti-inflammatory, antioxidant, and anticancer effects in preclinical studies.
- Dietary intake of flavones, including apigenin, is associated with lower incidence of several cancer types.
- Apigenin may offer protection against oxidative stress-related diseases like cardiovascular and neurological disorders.
Conclusions:
- Apigenin possesses promising chemopreventive potential against various cancers.
- While preclinical data is robust, human clinical trials are lacking.
- Further investigation is warranted to establish apigenin's efficacy and safety in disease prevention and treatment.
Related Concept Videos
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...